In contrast to luminal tumors, basal cancers are hormone receptor negative and Her2 negative, are more likely to be diagnosed in young, premenopausal women, are high grade with high proliferative index, and are associated with higher risk of recurrence [35–38]. The gene discussed is NR4A1; the disease is cancer.